WESDR

AcronymDefinition
WESDRWisconsin Epidemiologic Study of Diabetic Retinopathy
References in periodicals archive ?
In the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), a large population based study in 10 countries in southern Wisconsin, USA, the prevalence of any retinopathy in those with onset of diabetes after the age of 30 years (mostly with Type 2 DM) is 29% those within 5 years of diagnosis and 78% in those with diabetes duration more than 15 years2.
According to reports published by Wisconsin epidemiologic study of diabetic retinopathy (WESDR), diabetes mellitus was diagnosed [13].
As per WESDR (1991) at 20 years of duration of diabetes mellitus about 99% with type 1 and 60% with type 2 DM have some retinopathy.
In the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), 3.6% of patients with T1DM diagnosed at a younger age and 1.6% of those in whom T2DM developed in a later stage of life were considered blind [15].
Diyabetik retinopati ve DMO epidemiyolojisi hakkinda en onemli bilgileri veren "Wisconsin Epidemiologic Study of Diabetic Retinopathy" (WESDR)'ye gore 15 yillik bilinen diabetes mellitus'u takiben DMO prevalansi Tip I diabetes mellitus'ta yaklasik %20, insulin kullanan Tip II diabetes mellitus'lu hastalarda %25, insulin kullanmayan Tip II diabetes mellitus'lu hastalarda ise %14 olarak bildirilmistir.
Data from the population-based Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) study estimates the prevalence of diabetic macular edema (DME) in persons with 15 or more years of diabetes to be approximately 20% in those with type 1 diabetes; 25% in those with type 2 diabetes taking insulin and 14% in those with type 2 diabetes not taking insulin.1 To date, the only treatment conclusively demonstrated to be of long term benefit for diabetic macular edema is laser photocoagulation.
(1) The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), a population-based study in southern Wisconsin, estimated that after 20 years of known diabetes, the prevalence of diabetic macular edema (DME) was approximately 28% in both type 1 and type 2 diabetes.
Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) provides valuable information regarding both the prevalence and the risk factors associated with the development of diabetic retinopathy.
In the Wisconsin Epidemiology Study of Diabetic Retinopathy (WESDR), Klein et al.